CI=confidence interval; HR=hazard ratio; HRadj=adjusted hazard ratio; Ref=reference level. a Adjusted for positivity to the other HPV genus, age, lifetime number of sex partners, any sex in last interval, and new sex in last interval.b Positive for any type of the other HPV genus at previous visit; corresponds to betapapillomavirus positivity for columns where alphapapillomavirus incidence is the outcome, and alphapapillomavirus positivity for columns where betapapillomavirus incidence is the outcome.

References

1. International Agency for Research on Cancer. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100 (Pt B): 1-441.
2. Gheit T. Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology. Front Oncol 2019; 9 : 355.
3. Agalliu I, Gapstur S, Chen Z, et al. Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer.JAMA Oncology 2016; 2 (5): 599-606.
4. Tommasino M. The biology of beta human papillomaviruses. Virus Research 2017; 231 : 128-38.
5. Sabol I, Smahelova J, Klozar J, et al. Beta-HPV types in patients with head and neck pathology and in healthy subjects. Journal of Clinical Virology 2016; 82 : 159-65.
6. Altamura G, Tommasino M, Borzacchiello G. Cutaneous vs. Mucosal Tropism: The Papillomavirus Paradigm Comes to an ”and”. Front Microbiol 2020; 11 : 588663.
7. Bottalico D, Chen Z, Dunne A, et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis2011; 204 (5): 787-92.
8. Moscicki AB, Ma Y, Gheit T, et al. Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples. Open Forum Infect Dis 2017; 4 (1): ofw216.
9. Nunes EM, Sudenga SL, Gheit T, et al. Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study. Virology 2016; 495 : 33-41.
10. Hampras SS, Rollison DE, Giuliano AR, et al. Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites. The Journal of Infectious Diseases 2017;216 (1): 92-6.
11. Winer RL, Gheit T, Feng Q, et al. Prevalence and Correlates of β– and γ–Human Papillomavirus Detection in Oral Samples From Mid-Adult Women. The Journal of Infectious Diseases 2019; 219 (7): 1067-75.
12. Lang Kuhs KA, Gonzalez P, Struijk L, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.J Infect Dis 2013; 208 (10): 1643-52.
13. Carozzi F, Ronco G, Gillio-Tos A, et al. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012;48 (11): 1633-7.
14. Chaturvedi AK, Katki HA, Hildesheim A, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011; 203 (7): 910-20.
15. Mendez F, Munoz N, Posso H, et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005;192 (7): 1158-65.
16. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001; 184 (12): 1508-17.
17. Tota JE, Ramanakumar AV, Jiang M, et al. Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol 2013; 178 (4): 625-34.
18. Tota JE, Struyf F, Merikukka M, et al. Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials. J Natl Cancer Inst 2017; 109 (7).
19. Sichero L, El-Zein M, Nunes EM, Ferreira S, Franco EL, Villa LL. Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses. Cancer Epidemiol Biomarkers Prev 2017;26 (8): 1312-20.
20. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica1999; 6 (4): 223-33.
21. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38 (1): 357-61.
22. Gheit T, Billoud G, de Koning MNC, et al. Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. Journal of clinical microbiology 2007; 45 (8): 2537-44.
23. Berry KJ, Johnston JE, Mielke Jr PW. Permutation methods.WIREs Computational Statistics 2011; 3 (6): 527-42.
24. Lin DY, Wei LJ. The Robust Inference for the Cox Proportional Hazards Model. Journal of the American Statistical Association1989; 84 (408): 1074-8.
25. Scherpenisse M, Schepp RM, Mollers M, Meijer CJ, Berbers GA, van der Klis FR. Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses. PLoS One 2013; 8 (9): e74797.
26. Egawa N, Egawa K, Griffin H, Doorbar J. Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia. Viruses2015; 7 (7): 3863-90.
27. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of Mucosal Human Papillomavirus Types 6/11 in Cutaneous Lesions from Transplant Recipients. Journal of Investigative Dermatology 1993; 101 (3): 286-91.
28. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.Vaccine 2006; 24, Supplement 3 : S52-S61.
29. Plasmeijer EI, Green AC, de Koning MNC, et al. Transmission of betapapillomaviruses between domestic partners in an Australian community. Journal of Clinical Virology 2010; 47 (3): 216-8.
30. Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M, Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A 1978; 75 (3): 1537-41.
31. Smelov V, Muwonge R, Sokolova O, et al. Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants. Scientific Reports 2018; 8 (1): 8241.